Scimago Journal & Country Rank
menu
| Title | Type | SJR | H index |  Total Docs. (2008) |
Total Docs. (3years) | Total Refs. (2008) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2008) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 149 | Advances in Antiviral Drug Design | book series | 0.204 Q2 | 12 | 0 | 7 | 0 | 2 | 6 | 0.29 | 0.00 |  |
| 148 | Alimentary Pharmacology and Therapeutics, Supplement | journal | 1.100 Q1 | 69 | 0 | 67 | 0 | 188 | 63 | 0.00 | 0.00 | |
| 147 | Alimentary Pharmacology and Therapeutics Symposium Series | journal | 0.267 Q2 | 8 | 0 | 64 | 0 | 37 | 64 | 0.63 | 0.00 | |
| 146 | American Journal of Drug Delivery | journal | 0.375 Q3 | 23 | 0 | 49 | 0 | 63 | 43 | 1.64 | 0.00 | |
| 145 | American Journal of PharmacoGenomics | journal | 0.682 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 144 | Chemical Speciation and Bioavailability | journal | 0.420 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 143 | Progress in Pharmaceutical and Biomedical Analysis | book series | 0.148 Q3 | 8 | 0 | 14 | 0 | 7 | 12 | 0.00 | 0.00 | |
| 142 | Quality Assurance Journal | journal | 0.120 Q4 | 11 | 0 | 86 | 0 | 6 | 73 | 0.08 | 0.00 | |
| 141 | Signal | journal | 0.101 Q4 | 1 | 0 | 34 | 0 | 1 | 20 | 0.00 | 0.00 | |
| 140 | Toxicological Reviews | journal | 0.686 Q2 | 49 | 0 | 49 | 0 | 165 | 42 | 3.35 | 0.00 | |
| 139 | BMC Chemical Biology | journal | 1.042 Q1 | 21 | 3 | 8 | 101 | 23 | 8 | 3.20 | 33.67 | |
| 138 | Journal of Clinical Research | journal | 0.359 Q3 | 12 | 3 | 7 | 113 | 13 | 7 | 0.33 | 37.67 | |
| 137 | Journal of Immune Based Therapies and Vaccines | journal | 0.406 Q3 | 21 | 8 | 25 | 340 | 31 | 25 | 1.06 | 42.50 | |
| 136 | Paediatric and Perinatal Drug Therapy | journal | 0.233 Q3 | 20 | 9 | 64 | 192 | 45 | 54 | 0.74 | 21.33 | |
| 135 | Human Genomics | journal | 1.272 Q1 | 68 | 10 | 55 | 137 | 145 | 43 | 1.88 | 13.70 | |
| 134 | International Journal of Neuroprotection and Neuroregeneration | journal | 0.145 Q4 | 5 | 11 | 44 | 581 | 12 | 39 | 0.27 | 52.82 | |
| 133 | BMC Clinical Pharmacology | journal | 0.571 Q2 | 43 | 12 | 28 | 350 | 87 | 28 | 2.27 | 29.17 | |
| 132 | Journal of Applied Therapeutic Research | journal | 0.119 Q4 | 8 | 12 | 19 | 205 | 6 | 19 | 0.33 | 17.08 | |
| 131 | Journal of Negative Results in BioMedicine | journal | 0.542 Q1 | 25 | 12 | 41 | 351 | 70 | 41 | 1.97 | 29.25 | |
| 130 | Autonomic and Autacoid Pharmacology | journal | 0.382 Q3 | 24 | 13 | 112 | 439 | 107 | 111 | 0.97 | 33.77 | |
| 129 | Journal of Nanobiotechnology | journal | 1.400 Q1 | 109 | 14 | 34 | 457 | 165 | 32 | 4.12 | 32.64 | |
| 128 | Antiviral Chemistry and Chemotherapy | journal | 0.671 Q2 | 59 | 17 | 98 | 901 | 202 | 97 | 1.97 | 53.00 | |
| 127 | Chinese Medicine | journal | 0.366 Q3 | 56 | 17 | 17 | 777 | 43 | 16 | 2.53 | 45.71 | |
| 126 | Therapeutic Advances in Neurological Disorders | journal | 68 | 18 | 0 | 1083 | 0 | 0 | 0.00 | 60.17 | | |
| 125 | Toxin Reviews | journal | 0.174 Q4 | 54 | 19 | 69 | 1383 | 32 | 65 | 0.56 | 72.79 | |
| 124 | Drugs in Context | journal | 0.101 Q4 | 36 | 20 | 59 | 710 | 1 | 44 | 0.02 | 35.50 | |
| 123 | BMC Pharmacology | journal | 0.705 Q2 | 48 | 21 | 49 | 764 | 109 | 49 | 1.97 | 36.38 | |
| 122 | Food Additives and Contaminants: Part B Surveillance | journal | 41 | 22 | 0 | 622 | 0 | 0 | 0.00 | 28.27 | | |
| 121 | Particle and Fibre Toxicology | journal | 2.227 Q1 | 119 | 22 | 38 | 762 | 330 | 38 | 6.44 | 34.64 | |
| 120 | Drug Discovery Today: Technologies | journal | 0.429 Q3 | 62 | 23 | 135 | 863 | 176 | 123 | 0.90 | 37.52 | |
| 119 | Environmental Pollutants and Bioavailability | journal | 39 | 23 | 47 | 801 | 46 | 47 | 0.74 | 34.83 | | |
| 118 | Mathematical Medicine and Biology | journal | 0.669 Q2 | 49 | 23 | 58 | 703 | 120 | 57 | 1.69 | 30.57 | |
| 117 | Issues in Toxicology | book series | 0.114 Q4 | 18 | 25 | 26 | 3368 | 2 | 24 | 0.08 | 134.72 | |
| 116 | Nanotoxicology | journal | 1.034 Q1 | 107 | 25 | 26 | 1137 | 100 | 25 | 3.85 | 45.48 | |
| 115 | Journal of Liposome Research | journal | 0.817 Q1 | 64 | 26 | 73 | 1002 | 161 | 72 | 2.28 | 38.54 | |
| 114 | Drug Discovery World | journal | 0.184 Q4 | 14 | 27 | 114 | 245 | 35 | 103 | 0.34 | 9.07 | |
| 113 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.204 Q1 | 99 | 28 | 53 | 5091 | 239 | 50 | 3.78 | 181.82 | |
| 112 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 0.641 Q2 | 57 | 29 | 112 | 1475 | 207 | 104 | 1.83 | 50.86 | |
| 111 | Pharmaceutical Statistics | journal | 1.007 Q2 | 46 | 29 | 92 | 422 | 96 | 76 | 1.20 | 14.55 | |
| 110 | International Journal of Computational Biology and Drug Design | journal | 16 | 30 | 0 | 683 | 0 | 0 | 0.00 | 22.77 | | |
| 109 | CNS Neuroscience and Therapeutics | journal | 91 | 31 | 0 | 2582 | 0 | 0 | 0.00 | 83.29 | | |
| 108 | Cardiovascular Therapeutics | journal | 54 | 32 | 0 | 1922 | 0 | 0 | 0.00 | 60.06 | | |
| 107 | Cutaneous and Ocular Toxicology | journal | 0.179 Q4 | 37 | 34 | 82 | 722 | 44 | 80 | 0.67 | 21.24 | |
| 106 | Drug Discovery Today: Therapeutic Strategies | journal | 0.346 Q3 | 31 | 37 | 183 | 1854 | 145 | 167 | 0.81 | 50.11 | |
| 105 | BioDrugs | journal | 1.121 Q1 | 79 | 38 | 123 | 3093 | 420 | 117 | 2.97 | 81.39 | |
| 104 | Drug Discovery Today: Disease Mechanisms | journal | 0.208 Q4 | 28 | 38 | 197 | 2432 | 84 | 175 | 0.41 | 64.00 | |
| 103 | Drug Discovery Today: Disease Models | journal | 0.197 Q4 | 33 | 38 | 147 | 2088 | 67 | 131 | 0.49 | 54.95 | |
| 102 | Innovations in Pharmaceutical Technology | trade journal | 0.109 Q4 | 9 | 38 | 72 | 174 | 2 | 68 | 0.03 | 4.58 | |
| 101 | Molecular Diagnosis and Therapy | journal | 0.704 Q2 | 68 | 38 | 146 | 2967 | 342 | 141 | 2.46 | 78.08 | |
| 100 | Pharmaceutical Medicine | journal | 0.141 Q4 | 25 | 40 | 144 | 1355 | 40 | 129 | 0.37 | 33.88 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data